glp 1 compound ending GLP-1 Shortage = Over FDA crackdown on off-brand Ozempic

Physicians, employers and investors are watching closely as the market grows, supply ebbs and flows and new research emerges

GLP-1 medications belong to a class of drugs that include semaglutide, liraglutide, dulaglutide, and several others

In this class, we're seeing less of the big three heart outcomes, which is heart attack, stroke, and cardiovascular death

Effects of GLP-1RAs in clinical trials Clinical studies with focus on atherosclerotic CV disease

Its a great fit for those seeking a medically supervised, non-surgical approach with built-in accountability

It is also the only weight loss injection licensed to reduce cardiovascular risk (NICE, April 2026)